Does not require anesthesia, non-invasive, well tolerated.
An outpatient service and patient continues normal daily routines.
Current data demonstrates efficacy in patients who have struggled with medication.
May be good alternative for patients who responded to ECT in past.
No significant memory impairment.
FDA Approved in 2008 for the treatment of depression.
Facial twitching during the treatment.
Skin redness at site of coil placement.
Anxiety before and during treatment.
Mild discomfort (usually dissipates by end of first treatment).
Expense – Private Pay or limited third-party coverage.
Time – requires 30 treatment of an hour in length over 6 weeks.